Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Beam Therapeutics (BEAM) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Beam Therapeutics (BEAM) over the last 4 years, with Q3 2025 value amounting to 0.46%.

  • Beam Therapeutics' Return on Invested Capital fell 2400.0% to 0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year decrease of 2400.0%. This contributed to the annual value of 0.48% for FY2024, which is 2700.0% down from last year.
  • As of Q3 2025, Beam Therapeutics' Return on Invested Capital stood at 0.46%, which was down 2400.0% from 0.41% recorded in Q2 2025.
  • Beam Therapeutics' 5-year Return on Invested Capital high stood at 0.19% for Q1 2024, and its period low was 0.54% during Q4 2024.
  • Its 4-year average for Return on Invested Capital is 0.38%, with a median of 0.46% in 2025.
  • The largest annual percentage gain for Beam Therapeutics' Return on Invested Capital in the last 5 years was 2800bps (2024), contrasted with its biggest fall of -3400bps (2024).
  • Quarter analysis of 4 years shows Beam Therapeutics' Return on Invested Capital stood at 0.46% in 2022, then soared by 56bps to 0.2% in 2023, then crashed by -167bps to 0.54% in 2024, then increased by 15bps to 0.46% in 2025.
  • Its last three reported values are 0.46% in Q3 2025, 0.41% for Q2 2025, and 0.46% during Q1 2025.